ERCC1 and non-small cell lung carcinoma: Previous studies have found that ERCC1 rs3212986 is a genetic susceptibility factor for lung cancer and is associated with a reduced overall survival rate in patients with late-stage non-small cell lung cancer and decreased activity of the chemotherapy drug cisplatin [30–35].